Cordero Leandro, Rau Rachel, Taylor David, Ayers Leona W
Ohio State University, College of Medicine, Columbus, Ohio, USA.
Am J Infect Control. 2004 Jun;32(4):189-95. doi: 10.1016/j.ajic.2003.07.004.
To assess the occurrence of enteric gram-negative bacilli (EGNB) bloodstream infections (BSI) in a neonatal intensive care setting during a 17-year period in which a consistent antibiotic treatment program was in place. To document infections, outbreaks, or epidemics, emergence of antibiotic resistance, clinical correlates, and outcomes of the most prevalent EGNB (Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae).
This study analyzed demographic, clinical, and bacteriologic information from 360 infants born 1986-2002 who developed 633 blood culture-proven BSI. A total of 121 EGNB were isolated (E coli, K pneumoniae, and E cloacae). Early-onset BSI were discovered within 48 hours from birth, and late-onset BSI were those that occurred thereafter. Suspected early-onset BSI were treated with ampicillin and gentamicin, suspected late-onset BSI with vancomycin and gentamicin. Antibiotics were changed on the basis of organism antimicrobial susceptibility.
Early-onset BSI were noted in 52 of 21,336 (244/100,000) live births (1986-1991), 40 of 20,402 (196/100,000) live births (1992-1997), and 25 of 17,926 (139/100,000) live births (1998-2002). Of these cases, 39 were caused by E coli and 4 by K pneumoniae. Antibiograms for E coli isolated during the last 5 years of the study showed an increase in antibiotic resistance that coincided with obstetric group B streptococcus antepartum antibiotic prophylaxis. Group B streptococcus declined from 41 to 4 cases from the first to the last period. Late-onset BSI increased from 111 to 230 cases from the first to the second 6-year study period and declined modestly (171 cases) during the last. Fifteen percent (78 cases) of late-onset BSI were caused by EGNB, 5% by other gram-negative bacilli, 67% primarily by coagulase-negative staphylococcus, and 13% by fungus. Nonspecific clinical and hematologic signs of late-onset BSI were similar across EGNB species, but necrotizing enterocolitis was often associated with E coli, whereas pneumonia and prolonged thrombocytopenia characterized K pneumoniae infections. No outbreaks or epidemics were observed, and strains of EGNB with evidence of extended spectrum beta-lactamase production were never isolated.
Antepartum antibiotic prophylaxis may have increased antibiotic resistance in E coli isolates from early-onset BSI but has dramatically decreased group B streptococcus infections. Late-onset BSI caused by EGNB increased, but without changes in antibiotic susceptibility. In spite of medical advances, E coli, K pneumoniae, and E cloacae remain responsible for significant morbidity and mortality, especially in very low birth weight infants.
评估在实施持续抗生素治疗方案的17年期间,新生儿重症监护环境中肠革兰氏阴性杆菌(EGNB)血流感染(BSI)的发生情况。记录感染、暴发或流行情况、抗生素耐药性的出现、临床相关性以及最常见的EGNB(大肠杆菌、肺炎克雷伯菌和阴沟肠杆菌)的转归。
本研究分析了1986年至2002年出生的360例发生633次血培养证实的BSI的婴儿的人口统计学、临床和细菌学信息。共分离出121株EGNB(大肠杆菌、肺炎克雷伯菌和阴沟肠杆菌)。早发性BSI在出生后48小时内发现,晚发性BSI在此后发生。疑似早发性BSI用氨苄西林和庆大霉素治疗,疑似晚发性BSI用万古霉素和庆大霉素治疗。根据微生物药敏结果更换抗生素。
早发性BSI在21336例活产婴儿中有52例(244/100,000)(1986 - 1991年),20402例活产婴儿中有40例(196/100,000)(1992 - 1997年),17926例活产婴儿中有25例(139/100,000)(1998 - 2002年)。其中,39例由大肠杆菌引起,4例由肺炎克雷伯菌引起。研究最后5年分离出的大肠杆菌的抗菌谱显示抗生素耐药性增加,这与产科B族链球菌产前抗生素预防措施的实施一致。B族链球菌从第一阶段的41例降至最后阶段的4例。晚发性BSI从第一个6年研究期的111例增加到第二个6年研究期的230例,在最后一个阶段略有下降(171例)。15%(78例)的晚发性BSI由EGNB引起,5%由其他革兰氏阴性杆菌引起,67%主要由凝固酶阴性葡萄球菌引起,13%由真菌引起。晚发性BSI的非特异性临床和血液学体征在EGNB各菌种之间相似,但坏死性小肠结肠炎常与大肠杆菌相关,而肺炎和血小板减少持续时间延长是肺炎克雷伯菌感染的特征。未观察到暴发或流行,也从未分离出有超广谱β-内酰胺酶产生证据的EGNB菌株。
产前抗生素预防可能增加了早发性BSI分离出的大肠杆菌的抗生素耐药性,但显著降低了B族链球菌感染。由EGNB引起的晚发性BSI有所增加,但抗生素敏感性无变化。尽管医学取得了进展,但大肠杆菌、肺炎克雷伯菌和阴沟肠杆菌仍然是导致严重发病和死亡的原因,尤其是在极低出生体重儿中。